What does a typical case of Naegleria fowleri infection (primary amebic meningoencephalitis) look like in a previously healthy child or young adult after recent warm freshwater exposure, presented using the standard format of chief complaint (CC), history of present illness (HPI), physical examination (PE), laboratory findings, and signature signs?

Typical Presentation of Naegleria fowleri Infection (Primary Amebic Meningoencephalitis)

A typical case of PAM presents as a previously healthy child or young adult (median age 12 years) who develops severe headache, high fever, nausea, and vomiting 1-9 days after swimming or diving in warm freshwater, progressing within 24-72 hours to altered mental status, seizures, and coma, with death occurring 3-7 days after symptom onset despite treatment. 1

Chief Complaint (CC)

• Severe frontal headache (most common initial complaint)
• High fever
• Nausea and vomiting

History of Present Illness (HPI)

Timeline and Progression

The disease follows a characteristic biphasic pattern 1:

Early Phase (Days 1-3):

• Severe frontal headache (often described as "worst headache of life")
• High fever (typically 38.5-40°C)
• Nausea and vomiting
• Stiff neck
• Photophobia
• Changes in taste or smell (anosmia) - signature early finding

Late Phase (Days 3-7):

• Rapidly progressive altered mental status
• Confusion, lethargy progressing to coma
• Generalized tonic-clonic seizures
• Behavioral changes, hallucinations
• Cranial nerve palsies
• Hemoptysis (in severe cases) 2
• Respiratory failure and circulatory shock

Critical Exposure History

The key historical feature is warm freshwater exposure 1-9 days before symptom onset 1, 2:

• Swimming, diving, or water sports in lakes, ponds, rivers
• Hot spring bathing 3, 4
• Water skiing or jet skiing (forceful water entry into nose)
• Nasal irrigation with contaminated tap water
• Most exposures occur in summer months when water temperatures exceed 25°C (77°F)

Epidemiologic Pattern

• 83% of cases occur in children ≤18 years old (median age 12 years) 1
• 76% are male 1
• Previously healthy, immunocompetent individuals
• Historically southern US states, but now expanding northward (Minnesota, Kansas, Indiana cases documented) 1, 5

Physical Examination (PE)

Vital Signs

• High fever: 38.5-40°C
• Tachycardia
• Tachypnea (progressing to respiratory failure)
• Hypotension in late stages (shock)

Neurological Examination

Early findings:

• Nuchal rigidity (meningismus)
• Photophobia
• Positive Kernig's and Brudzinski's signs
• Intact mental status initially

Late findings (develop within 24-72 hours):

• Altered mental status: confusion → lethargy → stupor → coma
• Seizures (generalized tonic-clonic)
• Cranial nerve deficits (III, IV, VI palsies)
• Focal neurological deficits
• Decerebrate or decorticate posturing
• Loss of brainstem reflexes (terminal)

Other Findings

• Periorbital edema 3
• Signs of increased intracranial pressure

Laboratory Findings

Cerebrospinal Fluid (CSF) - Signature Findings

The CSF profile mimics bacterial meningitis but with key distinguishing features 1:

• Opening pressure: Markedly elevated (often >300 mm H₂O)
• Appearance: Turbid, hemorrhagic, or purulent
• White blood cell count: Elevated (median 2,400 cells/μL; range 5-26,000 cells/μL) 1
  • Predominantly neutrophils (unlike viral meningitis)
  • May show eosinophilia in some cases
• Glucose: Markedly decreased (median 23 mg/dL; range 1-92 mg/dL) 1
• Protein: Markedly elevated (median 365 mg/dL; range 24-1,210 mg/dL) 1
• Gram stain: Negative for bacteria
• Bacterial cultures: Negative (sterile)

Diagnostic CSF Studies:

• Fresh CSF wet mount: Shows motile amoebic trophozoites with characteristic "limax" (slug-like) movement - PATHOGNOMONIC 3, 6
• Wright-Giemsa stain: Reveals amoebic trophozoites (10-35 μm) with large nuclei and prominent karyosomes 3
• Metagenomic next-generation sequencing (mNGS): Detects N. fowleri DNA (copy numbers typically 10³-10⁵ copies/mL) 2, 4
• Immunofluorescence assay: Available through CDC

Blood Studies

• Leukocytosis with left shift
• Elevated inflammatory markers (CRP, ESR)
• Blood mNGS may detect N. fowleri 4

Neuroimaging Findings

MRI (Preferred)

Early imaging (first 24-48 hours) may be NORMAL 2 - critical pitfall

Later findings include:

• Gray matter involvement (cortical and deep gray matter)
• Obliteration of subarachnoid cisterns
• Hemorrhagic necrosis of olfactory bulbs and orbitofrontal cortex - signature finding
• Diffuse cerebral edema
• Hydrocephalus
• Enhancement of leptomeninges
• Brainstem involvement in advanced cases

CT Scan

• Often normal early in disease
• May show cerebral edema, effacement of sulci
• Hemorrhage in severe cases
• Useful for excluding contraindications to lumbar puncture

Signature Clinical Signs (High Specificity)

1. Anosmia or altered taste/smell - early sign from olfactory nerve involvement
2. Rapid progression from headache to coma within 3-5 days despite antibiotics
3. Hemorrhagic CSF with negative bacterial cultures and neutrophilic pleocytosis
4. Motile trophozoites on fresh CSF wet mount - pathognomonic
5. Recent warm freshwater exposure (especially diving/jumping into water)

Geographic Distribution

Historical Pattern

• Predominantly southern US states (Texas, Florida, Arizona, California)
• Tropical and subtropical regions worldwide

Emerging Pattern

PAM is expanding northward 5, 1:

• Recent cases in Minnesota, Kansas, Indiana
• Attributed to climate change and warming water temperatures
• Coastal regions now at risk 4

Critical Diagnostic Pitfalls

1. 75% of cases diagnosed postmortem 5 - disease progresses faster than diagnosis
2. Initial misdiagnosis as bacterial meningitis - CSF profile is nearly identical 6
3. Early neuroimaging may be completely normal 2
4. Failure to obtain detailed water exposure history - patients may not volunteer this information 4
5. CSF wet mount must be examined IMMEDIATELY - trophozoites lose motility as specimen cools
6. Routine bacterial meningitis treatment fails - no clinical improvement despite appropriate antibiotics

Outcome

• Mortality rate: 95-98% 7
• Death typically occurs 3-7 days after symptom onset (range 1-18 days) 1
• Only 5 documented survivors in North America (1962-2022) 7
• Survivors often have significant neurological sequelae

Key Clinical Pearls

Suspect PAM when:

• Acute meningoencephalitis in summer months
• Recent freshwater swimming/diving (especially in warm water)
• Rapid deterioration despite appropriate bacterial meningitis treatment
• CSF shows bacterial meningitis pattern but negative cultures
• Young, previously healthy patient
• Anosmia or taste changes precede neurological symptoms

Immediate actions if PAM suspected:

• Contact CDC Emergency Operations Center (770-488-7100) 24/7 1
• Perform fresh CSF wet mount examination immediately (before specimen cools)
• Send CSF for mNGS if available
• Initiate amphotericin B without waiting for confirmation
• Consider therapeutic hypothermia and aggressive ICP management

The diagnosis requires high clinical suspicion based on the combination of freshwater exposure history, fulminant clinical course, and characteristic CSF findings, as waiting for definitive microbiological confirmation is almost always fatal 8, 6.